FDA Details Herpes Tests that May Produce False Reactive Results
The FDA is providing this information to educate health care providers and clinical laboratory staff and reduce the risk of false results.
The FDA is providing this information to educate health care providers and clinical laboratory staff and reduce the risk of false results.
Using blood from a finger prick, the test probes hundreds of antibody responses to 14 respiratory viruses, including the cause of covid-19, in 2 to 4 hours.
The results are among the first to come from a collaborative validation study of covid-19 antibody tests by BARDA, CDC, FDA, and NIH.
The DPP Covid-19 IgM/IgG system is a single-use rapid point-of-care test for the detection and differentiation of IgM and IgG antibodies to covid-19 in whole blood.
Read More